组织样品检测

组织样品检测
  • 胸腺:研究T细胞分化、发育;

  • 淋巴结:T细胞、B细胞、DC细胞分析;

  • 骨髓:B细胞发育研究,红细胞发育研究,造血干细胞研究;

  • 肾组织:分析炎性细胞浸润;

  • 肺组织:小鼠肺组织中免疫细胞组成分析,肿瘤或炎症小鼠肺组织中免疫细胞浸润分析;

  • 皮肤:细胞炎性浸润分析;

  • 脑组织:分析组织中炎性细胞浸润情况。


实验案例一:胸腺T细胞发育


Population

Gating Step

Th Cells

Live single

mCD4+

mCD8-

 /

 /

Tc Cells

Live single

mCD4-

mCD8+

 /

 /

DP Cells

Live single

mCD4+

mCD8+

 /

/

DN Cells

Live single

mCD4-

mCD8-

 /

/

DN2 Cells

Live single

mCD4-

mCD8-

mCD44+

mCD25+

DN3 Cells

Live single

mCD4-

mCD8-

mCD44-

mCD25+

DN1 Cells

Live single

mCD4-

mCD8-

mCD44+

mCD25-

DN4 Cells

Live single

mCD4-

mCD8-

mCD44-

mCD25-


图片40.png

实验案例二:肾脏免疫细胞分析(12色方案)

Population

Gating Step

Total Leukocytes

Live single

mCD45+

/

/

/

Neutrophiles

Live single

mCD45+

mCD11b+

Ly6G+

/

Monocytes

Live single

Not Neutrophiles

mCD11b+

Ly6C hi

/

Eosinophils

Live single

Not monocytes

mCD11b+

SSC-H hi

/

Macrophage

Live single

Not eosinophils

mCD11b+

F4/80+

/

DC Cells

Live single

Not eosinophils

mCD11b+

mCD11c+

/

T Cells

Live single

Not eosinophils

mCD3+

mCD335-

/

B Cells

Live single

Not eosinophils

mCD19+

/

/

NK Cells

Live single

Not eosinophils

mCD3-

mCD335+

/

Th Cells

Live single

Not eosinophils

mCD3+

mCD4+

mCD8-

Tc Cells

Live single

Not eosinophils

mCD3+

mCD4-

mCD8+

图片41.png

实验案例三:脑组织浸润免疫细胞分析(10色方案)


Population

Gating step

Total Leukocytes

Live single

mCD45+

/

/

/

Neutrophiles

Live single

mCD45+

mCD11b+

Ly6G+

/

Monocytes

Live single

Not Neutrophiles

mCD11b+

Ly6C hi

/

Eosinophils

Live single

Not monocytes

mCD11b+

SSC-H hi

/

Macrophage

Live single

Not eosinophils

mCD11b+

F4/80+

/

T cells

Live single

Not eosinophils

mCD3+

mCD19-

/

B cells

Live single

Not eosinophils

mCD19+

mCD3-

/

Th

Live single

Not eosinophils

mCD3+

mCD4+

mCD8-

Tc

Live single

Not eosinophils

mCD3+

mCD4-

mCD8+


图片42.png

药康优势:

1. 拥有丰富的组织检测项目经验,不同组织有特异性的消化处理方法;

2. 提供常规流式检测Panel,同时可以根据药物特点,针对性的检测靶点或独特的细胞群体,提供定制化服务;

3. 严格的实验室数据保存方案,实验数据具有可追溯性 ,满足新药申报合规性要求。